Krensavage Asset Management Opposes Sun's Lowball Bid for Taro
/PRNewswire/ -- As the largest minority shareholder1 of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), Krensavage Asset Management LLC opposes Sun...
Why Shares of Taro Pharmaceutical Are Rising Tuesday
The company is mulling a buyout offer from Sun Pharmaceutical.
Taro Provides Results for December 31, 2022
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2022.
Taro to Release Third Quarter Results on January 24, 2023
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2022, after the close of market on Tuesday, January...